Oncolytics Biotech Inc. is a Canadian company headquartered in Calgary, Alberta, that is developing an intravenously delivered immuno-oncolytic virus called REOLYSIN® for the treatment of solid tumors and hematological malignancies.

Biotechnology

Oncolytics Biotech

Oncolytics Biotech's headquarters in Calgary, Canada

Jared Kelly

John McAdory

Andrew Aromando

Mary Ann Dillahunty

Allison Hagerman

Thomas C. Heineman

Kirk Look

Angela Holtham

Bernd R. Seizinger

James T. Parsons

Wayne Pisano

Deborah M. Brown

Jonathan Rigby

The Product Development and Regulatory Affairs team at Oncolytics Biotech is responsible for guiding the development of REOLYSIN® through its various stages, from pre-clinical to clinical trials. This team ensures that all products meet regulatory standards and quality requirements, while also overseeing drug safety and compliance with industry regulations. They collaborate closely with research, quality assurance, and translational science teams to facilitate the timely and successful advancement of innovative cancer therapies.

Product Development and Regulatory Affairs

The Leadership Team at Oncolytics Biotech is responsible for guiding the company's strategic vision and operational execution. This team, composed of senior executives including the President & CEO, CFO, and CMOs, oversees key areas such as product development, financial management, and overall business strategy to advance the development of REOLYSIN® and drive innovation in cancer treatment. They foster collaboration across departments to ensure alignment with the company's goals and regulatory compliance, ultimately aiming to enhance patient outcomes in oncology.

Leadership Team

The Clinical Operations team at Oncolytics Biotech is responsible for designing, implementing, and managing clinical trials to evaluate the safety and efficacy of REOLYSIN® in treating various cancers. This team ensures compliance with regulatory standards, collaborates with external partners, and oversees trial logistics to advance innovative treatments for solid tumors and hematological malignancies.

Oncolytics Biotech

Org chart

Board & advisors

Teams

Product Development and Regulatory Affairs

Leadership Team

Clinical Operations

Offices

Oncolytics Biotech

Org chart

Board & advisors

Teams

Product Development and Regulatory Affairs

Leadership Team

Clinical Operations

Offices

Related companies